140 related articles for article (PubMed ID: 31732994)
1. NUDT1: A potential independent predictor for the prognosis of patients with oral squamous cell carcinoma.
Shen Y; Zhang L; Piao S; Li L; Li J; Xia Y; Li J; Saiyin W
J Oral Pathol Med; 2020 Mar; 49(3):210-218. PubMed ID: 31732994
[TBL] [Abstract][Full Text] [Related]
2. Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma.
Ou Q; Ma N; Yu Z; Wang R; Hou Y; Wang Z; Chen F; Li W; Bi J; Ma J; Zhang L; Su Q; Huang X
Aging (Albany NY); 2020 Apr; 12(8):7363-7379. PubMed ID: 32341205
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
Zheng J; Wang F; Yang Y; Xu J; Yang J; Wang K; Liu Y; Du G; Zeng Y
J Oral Pathol Med; 2019 Sep; 48(8):686-695. PubMed ID: 31134698
[TBL] [Abstract][Full Text] [Related]
4. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
[TBL] [Abstract][Full Text] [Related]
5. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
6. Relationship of biglycan and decorin expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma.
Liu M; Wang W; Piao S; Shen Y; Li Z; Ding W; Li J; Saiyin W
J Oral Pathol Med; 2023 Jan; 52(1):20-28. PubMed ID: 36308714
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients.
Fang CY; Lin YH; Chen CL
J Oral Pathol Med; 2019 Sep; 48(8):712-719. PubMed ID: 31237374
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
10. High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.
Harada K; Ferdous T; Harada T; Ueyama Y
Clin Exp Med; 2017 Feb; 17(1):45-50. PubMed ID: 26590596
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
12. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum liver enzymes in oral and oropharynx squamous cell carcinomas.
Zhu Z; Zhou J; Xiong X; Liu D; Zheng Y; Ding X; Du Y; Gu N; Wu Y; Song X
J Oral Pathol Med; 2019 Jan; 48(1):36-42. PubMed ID: 30447114
[TBL] [Abstract][Full Text] [Related]
14. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
15. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
Rot S; Kaune T; Taubert H; Greither T; Kotrba J; Güttler A; Wichmann H; Bilkenroth U; Wienke A; Al-Nawas B; Bache M; Vordermark D; Wickenhauser C; Bethmann D; Eckert AW; Kappler M
BMC Cancer; 2019 Feb; 19(1):155. PubMed ID: 30770730
[TBL] [Abstract][Full Text] [Related]
17. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
18. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
[TBL] [Abstract][Full Text] [Related]
19. KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.
Shin WJ; Cho YA; Kang KR; Kim JH; Hong SD; Lee JI; Hong SP; Yoon HJ
APMIS; 2016 Apr; 124(4):291-8. PubMed ID: 26809635
[TBL] [Abstract][Full Text] [Related]
20. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
